skrub example report

Column	Column name	dtype	Null values	Unique values	Mean	Std	Min	Median	Max
0	ROW_ID	Int64DType	0 (0.0%)		6.01e+04	3.47e+04	0	60,107	120,214
1	PRODUCTID	ObjectDType	0 (0.0%)	120215 (100.0%)
2	PRODUCTNDC	ObjectDType	0 (0.0%)	117896 (98.1%)
3	PROPRIETARYNAME	ObjectDType	0 (0.0%)	45020 (37.4%)
4	PROPRIETARYNAMESUFFIX	ObjectDType	0 (0.0%)	4570 (3.8%)
5	NONPROPRIETARYNAME	ObjectDType	2 (< 0.1%)	19307 (16.1%)
6	DOSAGEFORMNAME	ObjectDType	0 (0.0%)	139 (0.1%)
7	ROUTENAME	ObjectDType	0 (0.0%)	193 (0.2%)
8	STARTMARKETINGDATE	Int64DType	0 (0.0%)		2.01e+07	1.14e+05	19,000,101	20,161,031	20,201,216
9	ENDMARKETINGDATE	ObjectDType	0 (0.0%)	677 (0.6%)
10	MARKETINGCATEGORYNAME	ObjectDType	0 (0.0%)	10 (< 0.1%)
11	APPLICATIONNUMBER	ObjectDType	0 (0.0%)	11257 (9.4%)
12	LABELERNAME	ObjectDType	0 (0.0%)	13388 (11.1%)
13	SUBSTANCENAME	ObjectDType	0 (0.0%)	9730 (8.1%)
14	ACTIVE_NUMERATOR_STRENGTH	ObjectDType	0 (0.0%)	10205 (8.5%)
15	ACTIVE_INGRED_UNIT	ObjectDType	0 (0.0%)	2928 (2.4%)
16	PHARM_CLASSES	ObjectDType	0 (0.0%)	1320 (1.1%)
17	DEASCHEDULE	ObjectDType	0 (0.0%)	5 (< 0.1%)
18	NDC_EXCLUDE_FLAG	ObjectDType	0 (0.0%)	1 (< 0.1%)
19	LISTING_RECORD_CERTIFIED_THROUGH	ObjectDType	0 (0.0%)	3 (< 0.1%)

Column 1	Column 2	Cramér's V
PRODUCTID	PRODUCTNDC	0.943
ENDMARKETINGDATE	LISTING_RECORD_CERTIFIED_THROUGH	0.707
NONPROPRIETARYNAME	SUBSTANCENAME	0.618
MARKETINGCATEGORYNAME	APPLICATIONNUMBER	0.498
APPLICATIONNUMBER	SUBSTANCENAME	0.477
ROUTENAME	ACTIVE_INGRED_UNIT	0.465
SUBSTANCENAME	ACTIVE_INGRED_UNIT	0.450
ROUTENAME	SUBSTANCENAME	0.409
STARTMARKETINGDATE	LABELERNAME	0.397
ROUTENAME	MARKETINGCATEGORYNAME	0.393
ROUTENAME	LABELERNAME	0.392
MARKETINGCATEGORYNAME	ACTIVE_INGRED_UNIT	0.370
DOSAGEFORMNAME	ROUTENAME	0.370
DOSAGEFORMNAME	MARKETINGCATEGORYNAME	0.362
DOSAGEFORMNAME	APPLICATIONNUMBER	0.348
DOSAGEFORMNAME	ACTIVE_INGRED_UNIT	0.348
MARKETINGCATEGORYNAME	PHARM_CLASSES	0.340
DOSAGEFORMNAME	LABELERNAME	0.339
MARKETINGCATEGORYNAME	LABELERNAME	0.337
PROPRIETARYNAME	NONPROPRIETARYNAME	0.333

Please enable javascript

The skrub table reports need javascript to display correctly. If you are displaying a report in a Jupyter notebook and you see this message, you may need to re-execute the cell or to trust the notebook (button on the top right or "File > Trust notebook").

	ROW_ID	PRODUCTID	PRODUCTNDC	PROPRIETARYNAME	PROPRIETARYNAMESUFFIX	NONPROPRIETARYNAME	DOSAGEFORMNAME	ROUTENAME	STARTMARKETINGDATE	ENDMARKETINGDATE	MARKETINGCATEGORYNAME	APPLICATIONNUMBER	LABELERNAME	SUBSTANCENAME	ACTIVE_NUMERATOR_STRENGTH	ACTIVE_INGRED_UNIT	PHARM_CLASSES	DEASCHEDULE	NDC_EXCLUDE_FLAG	LISTING_RECORD_CERTIFIED_THROUGH
	ROW_ID	PRODUCTID	PRODUCTNDC	PROPRIETARYNAME	PROPRIETARYNAMESUFFIX	NONPROPRIETARYNAME	DOSAGEFORMNAME	ROUTENAME	STARTMARKETINGDATE	ENDMARKETINGDATE	MARKETINGCATEGORYNAME	APPLICATIONNUMBER	LABELERNAME	SUBSTANCENAME	ACTIVE_NUMERATOR_STRENGTH	ACTIVE_INGRED_UNIT	PHARM_CLASSES	DEASCHEDULE	NDC_EXCLUDE_FLAG	LISTING_RECORD_CERTIFIED_THROUGH
0	0	0002-0800_03155cd7-d92b-480b-8a86-087659b6990f	0002-0800	Sterile Diluent	?	diluent	INJECTION, SOLUTION	SUBCUTANEOUS	19870710	?	BLA	BLA018781	Eli Lilly and Company	WATER	1	mL/mL	?	?	N	20211231.0
1	1	0002-1200_480fceef-6596-4478-97de-677c155506b3	0002-1200	Amyvid	?	Florbetapir F 18	INJECTION, SOLUTION	INTRAVENOUS	20120601	?	NDA	NDA202008	Eli Lilly and Company	FLORBETAPIR F-18	51	mCi/mL	Radioactive Diagnostic Agent [EPC],Positron Emitting Activity [MoA]	?	N	20211231.0
2	2	0002-1210_151a431b-f07b-4959-b6fa-c41ff80364c8	0002-1210	TAUVID	?	Flortaucipir F-18	INJECTION, SOLUTION	INTRAVENOUS	20200528	?	NDA	NDA212123	Eli Lilly and Company	FLORTAUCIPIR F-18	51	mCi/mL	?	?	N	20211231.0
3	3	0002-1433_ed8cc753-cd37-42a1-9c11-1401b40d94a5	0002-1433	Trulicity	?	Dulaglutide	INJECTION, SOLUTION	SUBCUTANEOUS	20140918	?	BLA	BLA125469	Eli Lilly and Company	DULAGLUTIDE	.75	mg/.5mL	GLP-1 Receptor Agonist [EPC],Glucagon-Like Peptide 1 [CS],Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]	?	N	20211231.0
4	4	0002-1434_ed8cc753-cd37-42a1-9c11-1401b40d94a5	0002-1434	Trulicity	?	Dulaglutide	INJECTION, SOLUTION	SUBCUTANEOUS	20140918	?	BLA	BLA125469	Eli Lilly and Company	DULAGLUTIDE	1.5	mg/.5mL	GLP-1 Receptor Agonist [EPC],Glucagon-Like Peptide 1 [CS],Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]	?	N	20211231.0

120210	120210	99207-465_3c27c96e-5556-4f4e-9971-a3c2d75796c2	99207-465	Solodyn	?	minocycline hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20100927	?	NDA	NDA050808	Bausch Health US LLC	MINOCYCLINE HYDROCHLORIDE	55	mg/1	Tetracycline-class Drug [EPC],Tetracyclines [CS]	?	N	20211231.0
120211	120211	99207-466_3c27c96e-5556-4f4e-9971-a3c2d75796c2	99207-466	Solodyn	?	minocycline hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20100927	?	NDA	NDA050808	Bausch Health US LLC	MINOCYCLINE HYDROCHLORIDE	80	mg/1	Tetracycline-class Drug [EPC],Tetracyclines [CS]	?	N	20211231.0
120212	120212	99207-467_3c27c96e-5556-4f4e-9971-a3c2d75796c2	99207-467	Solodyn	?	minocycline hydrochloride	TABLET, FILM COATED, EXTENDED RELEASE	ORAL	20100927	?	NDA	NDA050808	Bausch Health US LLC	MINOCYCLINE HYDROCHLORIDE	105	mg/1	Tetracycline-class Drug [EPC],Tetracyclines [CS]	?	N	20211231.0
120213	120213	99207-525_c62955d3-4537-414a-8b06-c8dd300d0f50	99207-525	Vanos	?	fluocinonide	CREAM	TOPICAL	20060313	?	NDA	NDA021758	Bausch Health US LLC	FLUOCINONIDE	1	mg/g	Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]	?	N	20211231.0
120214	120214	99207-850_e52ec481-1114-4f09-9be0-311e5eb52fa1	99207-850	Luzu	?	LULICONAZOLE	CREAM	TOPICAL	20131114	?	NDA	NDA204153	Bausch Health US, LLC	LULICONAZOLE	10	mg/g	Azole Antifungal [EPC],Azoles [CS],Cytochrome P450 2C19 Inhibitors [MoA]	?	N	20211231.0

Drug directory

ROW_ID

PRODUCTID

PRODUCTNDC

PROPRIETARYNAME

PROPRIETARYNAMESUFFIX

NONPROPRIETARYNAME

DOSAGEFORMNAME

ROUTENAME

STARTMARKETINGDATE

ENDMARKETINGDATE

MARKETINGCATEGORYNAME

APPLICATIONNUMBER

LABELERNAME

SUBSTANCENAME

ACTIVE_NUMERATOR_STRENGTH

ACTIVE_INGRED_UNIT

PHARM_CLASSES

DEASCHEDULE

NDC_EXCLUDE_FLAG

LISTING_RECORD_CERTIFIED_THROUGH